Is KYMR a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Kymera Therapeutics Inc (KYMR) is (190.15) USD. With the latest stock price at 33.87 USD, the upside of Kymera Therapeutics Inc based on DCF is -661.4%. This means that KYMR is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 8.6% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (389.59) - (127.38) | (190.15) |
| Upside | -1250.3% - -476.1% | -661.4% |